# Dose and Concentration Relationship for PENG Block in Hip Surgery

> **NCT05400148** · — · COMPLETED · sponsor: **Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization** · enrollment: 112 (actual)

## Conditions studied

- Hip Fractures
- Post Operative Pain

## Interventions

- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT05400148
- **Lead sponsor:** Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-05
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05400148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05400148, "Dose and Concentration Relationship for PENG Block in Hip Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05400148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*